Cancer drug discovery Archive — Page 1 of 2
-
June 23, 2016
VU takes key role in cancer drug discovery consortium
Vanderbilt University has been selected as one of seven Dedicated Centers in the nation for the next phase of the Chemical Biology Consortium (CBC), a national network of scientists on the leading edge of cancer drug discovery. -
May 5, 2016
Current cancer drug discovery method flawed: VUMC study
The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods. -
July 27, 2015
Anticancer olive compounds
Compounds found in olives and olive oil have anticancer activity, which may contribute to the cancer preventive properties attributed to the Mediterranean diet. -
April 8, 2015
Micelle “packets” deliver cancer drugs
Vanderbilt researchers designed micelle “packets” to selectively deliver anti-cancer drugs to breast cancer cells. -
April 3, 2015
Cancer signaling pathway blocker
Researchers at Vanderbilt University have discovered a new way to inhibit Hedgehog (Hh) signaling, an important regulatory pathway for vertebrate development – and cancer. -
February 25, 2015
Antibiotics with anticancer potential
A series of experimental antibiotics may be a good starting point for developing new anticancer drugs. -
November 12, 2014
New insight on oral cancer culprits
A new mouse model offers insight into the signaling pathways that control oral cancers – and a platform for testing anticancer therapeutics.